13 signals · bluesky, newsapi, News / RSS
Scores are directional signals derived from aggregated public data — not verified findings or investment advice. Methodology
Signal-based estimates from public data — not verified assessments. Learn more
Some stress signals present but below significant thresholds.
Low risk signals — no significant operational or reputational pressure detected.
Signals suggest Futura Medical has mixed developments in its partnerships and product distribution.
With a medium stress level and low risk level, patterns indicate that Futura Medical is navigating its partnerships, as evidenced by the end of its US partnership with Haleon PLC and the lining up of a new distributor for its erectile dysfunction treatment Eroxon, but our confidence is limited to 42.1/100 due to the relatively low number of reviews. Coverage is limited, but signals also mention a new partnership with MPG for US sales. However, the overall sentiment of the signals is not strongly positive or negative, reflecting the mixed nature of these developments.
What this means
Signals suggest a mixed picture — review the evidence below for context.
Futura Medical partners with MPG for US sales a... Pluang
Futura Medical partners with MPG for US sales a...
Sunset of the Drop-Top Compact: This 1965 Ford Falcon Futura Convertible Represents the Final Production Run of its Generation en.wheelz.me/1965-ford-fa...
Futura swaps Haleon for Market Performance Group to drive US Eroxon sales. Futura Medical PLC (AIM:FUM, OTC:FAMDF, FRA:GYX) has ended its US partnership with consumer health giant Haleon PLC (LSE:HLN, NYSE:HLN) and lined up a new distributor for its erectile dysfunction treatment Eroxon. The group, which specialises in clinically pr…
Digitizing dentistry in LatAm
Based on 13 signals across 3 sources · snapshot 12 Jul 2026
Moderate — directional but may shift as more signals arrive.
Overall community sentiment for FUTURA is positive based on public signals as of 12 Jul 2026.
Based on 13 signals across 3 sources
Scores are directional signals derived from public data — not certified assessments or recommendations. Confidence indicates data coverage, not accuracy. Learn how scores are calculated →
Derived from public sources such as news, filings, and reported events.
Healthtech industry average
AI-generated from public signals — may be incomplete. Based on 3 recent signals.
This summary is generated from publicly available review and signal data. It is intended as an indicative overview only and should not be used as the sole basis for employment, investment, or business decisions. Signal volume and source diversity may limit representativeness.
AI summaries are generated from public signals and may not reflect the full picture.
Futura Medical PLC (AIM:FUM, OTC:FAMDF, FRA:GYX) has ended its US partnership with consumer health giant Haleon PLC (LSE:HLN, NYSE:HLN) and lined up a new distributor for its erectile dysfunction treatment Eroxon.
Healthtech